Return to search

Bridge Growth Partners appoints ex-Ikaria chairman/CEO as senior advisor

Bridge Growth Partners has hired Daniel Tassé as a senior advisor. Also, Tassé will join Bridge Growth’s strategic advisory board. Tassé is the former chairman and CEO of
Ikaria Inc.

PRESS RELEASE

Bridge Growth Partners, LLC today announced that Daniel Tassé, former Chairman and Chief Executive Officer of Ikaria, Inc., has joined Bridge Growth Partners as a Senior Advisor and will also serve on its Strategic Advisory Board.

“Daniel is one of the most strategically effective and successful operating CEOs I have ever worked with,” said Alok Singh, Co-Founder and Managing Principal of Bridge Growth Partners. “His strong background in developing and delivering innovative medical technology products and services, keen understanding of regulatory affairs and insightful appreciation of emerging trends driven by the intersection of digital technology and managed care will help identify interesting investment opportunities for Bridge Growth. Daniel will add significantly to the operating experience and industry expertise that resides in our Strategic Advisory Board. We are delighted to have Daniel join our team.”

Mr. Tassé said, “I am thrilled to be joining Bridge Growth Partners. I’m looking forward to working closely with such a talented and engaged leadership team and with the world class Strategic Advisory Board they have established. I am confident that as the firm continues to grow, I will be able to deploy my extensive experience and relationships in technology and healthcare to actively contribute to the firm’s efforts to source, execute and bring value to exciting and promising investment opportunities on behalf of its investors.”

Sander Levy, Co-Founder and Managing Principal of Bridge Growth Partners added, “We are excited to welcome Daniel to Bridge Growth. His successful track record of business building and delivering value to investors is very much aligned with our firm’s investment philosophy. Bridge Growth will benefit greatly from Daniel’s varied experiences as we identify new investments and build value in our portfolio companies.”

Mr. Tassé is an accomplished healthcare and technology executive. From 2008 until 2015, he served as Chairman and Chief Executive Officer of Ikaria Inc., a leading global critical care company focused on developing and commercializing innovative therapies for critically ill patients. In 2013, Mr. Tassé successfully led Ikaria’s split into two companies —Ikaria and Bellerophon Therapeutics—and in April 2015 he completed the sale of Ikaria to Mallinckrodt for $2.3 billion.

Prior to his work with Ikaria, Mr. Tassé ran the pharmaceutical technologies business unit of Baxter, a global business with $2 billion in revenue generated across contract manufacturing, drug delivery technologies, and generic drugs. Before joining Baxter, Mr. Tassé was based in Australia, where he was responsible for the Australasian business of GlaxoSmithKline. Prior to that, he worked at SmithKline Beecham—the precursor to GlaxoSmithKline—where he was responsible for product development, sales, and marketing for the Company’s health care services division. Mr. Tassé is currently a Director of Indivior and Bellerophon Therapeutics. He is also a Senior Advisor to Athyrium Capital Management, a specialist in structured investments in the global healthcare sector. Mr. Tassé recently joined the Sheikh Zayed Institute Business Advisory Council at the Children’s National Health System in Washington, DC.

He holds a B.Sc. in Biochemistry from Université de Montreal and is fluent in both French and English.
In addition to Mr. Tassé, the Bridge Growth Partners Strategic Advisory Board includes:

Joseph Tucci, Chairman and Chief Executive Officer of EMC Corporation and Chairman of VMware

Jessica M. Bibliowicz, former Chairman and Chief Executive Officer of National Financial Partners

Yves de Balmann, former Co-Chairman of Bregal Investments and Co-Chief Executive Officer of Deutsche Bank Alex. Brown

Fred H. Langhammer, Chairman, Global Affairs, of The Estee Lauder Companies Inc.

The Honourable John Manley, Chairman of CIBC, Chief Executive Officer of the Canadian Council of Chief Executives and former Deputy Prime Minister and Finance Minister of Canada

The Honorable Tom Ridge, former Secretary of the U.S. Department of Homeland Security and former Governor of Pennsylvania

Phil Scanlan, former Australian Consul-General in New York

Sy Sternberg, former Chairman and Chief Executive Officer of New York Life Insurance

Myron Trepper, former Co-Chairman of Willkie Farr & Gallagher LLP

About Bridge Growth Partners
Bridge Growth Partners, LLC brings together significant investment, financial, operating and strategic business building expertise and talent for the purpose of investing in carefully selected, growing and important segments of the technology and financial services sectors. For more information visit www.bridgegrowthpartners.com.